These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15156214)

  • 41. [H. pylori infection].
    Asaka M; Kato M
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():303-10. PubMed ID: 11838131
    [No Abstract]   [Full Text] [Related]  

  • 42. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 43. Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs.
    Savarino V; Vigneri S; Celle G
    Lancet; 1998 Dec 19-26; 352(9145):2016-7. PubMed ID: 9872270
    [No Abstract]   [Full Text] [Related]  

  • 44. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
    Zullo A; Cristofari F; Hassan C
    Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
    [No Abstract]   [Full Text] [Related]  

  • 45. Loss of non-steroidal anti-inflammatory drug hypersensitivity after Helicobacter pylori eradication.
    Neynaber S; Berking C; Przybilla B
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):196-7. PubMed ID: 18507698
    [No Abstract]   [Full Text] [Related]  

  • 46. Helicobacter pylori infection and surgical disease---part I.
    Stabile BE; Smith BR; Weeks DL
    Curr Probl Surg; 2005 Nov; 42(11):756-89. PubMed ID: 16310017
    [No Abstract]   [Full Text] [Related]  

  • 47. [From a controversial minor finding to the Nobel Prize. The discovery of Helicobacter pylori--an unlikely tale of success].
    Engstrand L; Enroth H
    Lakartidningen; 2005 Dec 5-11; 102(49):3779-80, 3785-6. PubMed ID: 16408701
    [No Abstract]   [Full Text] [Related]  

  • 48. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract]   [Full Text] [Related]  

  • 49. More about Helicobacter pylori, antibiotics and IBD.
    Guslandi M
    Helicobacter; 2004 Oct; 9(5):469; author reply 469-70. PubMed ID: 15361088
    [No Abstract]   [Full Text] [Related]  

  • 50. Observational studies on prescription practices: interpret with caution.
    Savarino V; Dulbecco P
    Dig Liver Dis; 2010 May; 42(5):348-9. PubMed ID: 20356810
    [No Abstract]   [Full Text] [Related]  

  • 51. Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
    Baker DE
    Rev Gastroenterol Disord; 2008; 8(1):33-41. PubMed ID: 18477968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
    Schaeverbeke T; Broutet N; Zerbib F; Combe B; Bertin P; Lamouliatte H; Perié F; Joubert-Collin M; Mégraud F
    Am J Gastroenterol; 2005 Dec; 100(12):2637-43. PubMed ID: 16393213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori infection: a clinical overview.
    Kandulski A; Selgrad M; Malfertheiner P
    Dig Liver Dis; 2008 Aug; 40(8):619-26. PubMed ID: 18396114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
    Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
    Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The history of Helicobacter pylori: a reflection on the relationship between the medical community and industry.
    Ciacci C; Mazzacca G
    Dig Liver Dis; 2006 Oct; 38(10):778-80. PubMed ID: 16870518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eradication rate of Helicobacter pylori in dyspeptic patients.
    Amini M; Khedmat H; Yari F
    Med Sci Monit; 2005 Apr; 11(4):CR193-5. PubMed ID: 15795700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lettsomian lecture. Helicobacter pylori--the germ at the bottom of your stomach.
    Pounder R
    Trans Med Soc Lond; 1997-1998; 114():65-71. PubMed ID: 10824258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.